1.
Hematol., Transfus. Cell Ther. (Impr.)
; 44(1): 95-99, Jan.-Mar. 2022. tab
Artigo
em Inglês
| LILACS
| ID: biblio-1364881
RESUMO
Abstract Hemochromatosis is currently characterized by the iron overload caused by hepcidin deficiency. Large advances in the knowledge on the hemochromatosis pathophysiology have occurred due to a better understanding of the protein of the iron metabolism, the genetic basis of hemochromatosis and of other iron overload diseases or conditions which can lead to this phenotype. In the present review, the main aims are to show updates on hemochromatosis and to report a practical set of therapeutic recommendations for the human factors engineering protein (HFE) hemochromatosis for the p.Cys282Tyr (C282Y/C282Y) homozygous genotype, elaborated by the Haemochromatosis International Taskforce.
Assuntos
Humanos , Masculino , Feminino , Distúrbios do Metabolismo do Ferro , Hemocromatose/diagnóstico , Hemocromatose/terapia , Flebotomia , Sobrecarga de Ferro , Hepcidinas/deficiência , Proteína da Hemocromatose
2.
Acta Haematol
; 124(4): 204-5, 2010.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21071928